Medpace Holdings (MEDP) Notes Payables (2022 - 2023)
Medpace Holdings' (MEDP) quarterly Notes Payables came in at $55.0 million in Q2 2023, down 77.97% YoY from $249.7 million in Q2 2022, and down 52.17% on a QoQ basis from $115.0 million in Q1 2023.
Medpace Holdings (MEDP) Notes Payables (2022 - 2023) Analysis & Trends
Medpace Holdings (MEDP) has 2 years of Notes Payables data on file, last reported at $55.0 million in Q2 2023.
- Quarterly Notes Payables fell 77.97% year-over-year to $55.0 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $55.0 million (down 77.97% YoY) and the FY2022 annual result came in at $50.0 million, changed N/A from the prior year.
- Notes Payables slipped to $55.0 million in Q2 2023, from $115.0 million in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $249.7 million in Q2 2022 to a low of $50.0 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Medpace Holdings | 16.54 Bn | 16.03 Bn | 201.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 55.00 Mn |
| Mar 31, 2023 | 115.00 Mn |
| Dec 31, 2022 | 50.00 Mn |
| Sep 30, 2022 | 139.70 Mn |
| Jun 30, 2022 | 249.70 Mn |